Molecular and Cellular Mechanisms of Diabetic Retinopathy

Dear Colleagues,

We are pleased to announce the call for submissions to our upcoming Special Issue titled “Molecular and Cellular Mechanisms of Diabetic Retinopathy”. Diabetic retinopathy is a severe ophthalmic complication affecting the retina and the leading cause of vision loss in adult diabetic patients. Although anti-VEGF therapy is widely accepted to be the pharmacological gold standard for diabetic retinopathy, its management remains challenging.

Given the significant impact of diabetic retinopathy on public health, there is an urgent need for novel comprehensive research to understand the cellular and molecular mechanisms underlying its pathophysiology to identify novel therapeutic targets for modulation, thus improving overall patient outcomes.

By shedding light on novel cellular and molecular pathways potentially involved in the development of neuronal and mitochondrial dysfunction, inflammation, oxidative stress, fibrosis and vascular abnormalities in diabetic retina, this Special Issue will provide new insights and discoveries through research on diabetic retinopathy by suggesting the modulation of specific retinal cellular and molecular targets as new preventive or therapeutic strategies to improve diabetic retinopathy management.

This Special Issue will consider original research and review articles on new scientific developments related to the cellular and molecular mechanisms implicated in the prevention, progression and resolution of diabetic retinopathy.

Dr. Maria Consiglia Trotta
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• diabetes
• diabetic retinopathy
• inflammation
• pro-resolving mediators
• fibrosis
• epithelial–mesenchymal transition
• microRNAs